ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ZBH on NYSE
Shares outstanding
197,298,777
Price per share
$89.92
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
191,147,462
Holdings value
$18,828,338,014
% of all portfolios
0.01%
Share change
-781,425
Value change
-$50,373,346
Average buys %
+0%
Average sells %
-0%
Number of holders
950
Price from insider filings
$97.52
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DODGE & COX 11% +10% $2,380,117,740 +$216,534,260 22,097,463 +10% Dodge & Cox 30 Jun 2025
BlackRock, Inc. 7.8% $1,592,514,103 15,573,187 BlackRock, Inc. 31 Mar 2025
As of 30 Sep 2025, ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH) has 950 institutional shareholders filing 13F forms. They hold 191,147,462 shares of 197,298,777 outstanding shares (97%) .

Top 25 institutional shareholders own 74% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 23,291,224 +0.17% 0.03% $2,294,185,565
Dodge & Cox 12% 23,216,173 +5.1% 1.2% $2,286,793,041
BlackRock, Inc. 8.2% 16,149,859 +0.21% 0.03% $1,590,761,196
PRICE T ROWE ASSOCIATES INC /MD/ 7.6% 15,082,438 +1.9% 0.16% $1,485,621,000
STATE STREET CORP 4.4% 8,631,760 -1.3% 0.03% $852,260,365
Capital International Investors 3.8% 7,550,754 +11% 0.12% $743,749,269
GEODE CAPITAL MANAGEMENT, LLC 2.6% 5,197,223 +1.4% 0.03% $509,869,393
AMERICAN CENTURY COMPANIES INC 2.6% 5,176,696 -9.3% 0.26% $509,904,828
HARRIS ASSOCIATES L P 2.4% 4,750,567 +27% 0.75% $467,930,836
FRANKLIN RESOURCES INC 2.4% 4,668,130 -0.12% 0.12% $459,810,810
PRIMECAP MANAGEMENT CO/CA/ 2.2% 4,250,630 -9.8% 0.32% $418,687,055
AMERIPRISE FINANCIAL INC 1.9% 3,789,200 +1.6% 0.09% $373,239,165
VAN ECK ASSOCIATES CORP 1.8% 3,476,906 +2.4% 0.32% $342,475,000
Invesco Ltd. 1.5% 3,038,386 -34% 0.05% $299,281,025
DIMENSIONAL FUND ADVISORS LP 1.2% 2,269,122 +1.8% 0.05% $223,503,349
NORTHERN TRUST CORP 1.1% 2,109,159 -3.5% 0.03% $207,752,164
VICTORY CAPITAL MANAGEMENT INC 0.98% 1,924,763 +25% 0.13% $198,617,499
MORGAN STANLEY 0.86% 1,693,307 -7.9% 0.01% $166,791,020
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 0.82% 1,610,361 -1.2% 0.49% $158,620,559
Legal & General Group Plc 0.76% 1,508,797 +1.1% 0.03% $148,616,511
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.76% 1,499,156 -18% 0.03% $147,666,868
EQUITY INVESTMENT CORP 0.73% 1,441,955 -0.77% 3% $142,032,544
ROYAL BANK OF CANADA 0.71% 1,406,087 +37% 0.02% $138,500,000
Bank of New York Mellon Corp 0.71% 1,397,375 -2.3% 0.02% $137,641,402
BANK OF AMERICA CORP /DE/ 0.68% 1,332,954 +5.9% 0.01% $131,295,966

Institutional Holders of ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 799,645 $72,335,081 +$21,365,749 $89.92 27
2025 Q3 191,147,462 $18,828,338,014 -$50,373,346 $98.50 950
2025 Q2 192,626,878 $17,571,714,234 +$792,544,401 $91.21 924
2025 Q1 182,528,864 $20,656,200,217 +$77,640,432 $113.18 986
2024 Q4 181,928,665 $19,210,816,246 +$176,339,110 $105.63 1,007
2024 Q3 178,803,166 $19,279,742,285 -$757,008,449 $107.95 965
2024 Q2 185,900,021 $20,171,708,275 +$315,702,723 $108.53 990
2024 Q1 183,001,806 $24,129,924,379 +$189,541,478 $131.98 1,000
2023 Q4 2,377,333 $289,315,549 -$31,559,761 $121.70 11
2023 Q3 178,411,365 $20,011,256,422 -$307,590,396 $112.22 991
2023 Q2 180,824,601 $26,305,988,130 -$178,131,114 $145.60 1,009
2023 Q1 182,462,846 $23,570,978,501 -$210,166,542 $129.20 968
2022 Q4 184,227,650 $23,486,074,545 +$26,247,081 $127.50 954
2022 Q3 179,779,335 $18,806,741,073 +$304,137,119 $104.55 889
2022 Q2 186,691,694 $19,613,645,816 -$175,119,780 $105.06 918
2022 Q1 185,295,123 $23,696,331,632 +$753,606,779 $127.90 934
2021 Q4 186,322,518 $23,678,114,289 -$193,273,715 $127.04 959
2021 Q3 185,992,517 $27,233,774,390 -$192,238,684 $146.36 951
2021 Q2 186,937,280 $30,063,790,865 +$469,631,004 $160.82 998
2021 Q1 186,321,085 $29,833,998,669 +$372,095,382 $160.08 1,008
2020 Q4 184,118,458 $28,370,329,654 +$232,225,562 $154.09 983
2020 Q3 183,023,463 $24,887,253,556 -$280,903,013 $136.14 907
2020 Q2 185,161,687 $22,104,817,008 +$293,911,684 $119.36 926
2020 Q1 180,851,004 $18,269,257,589 -$132,894,553 $101.08 855
2019 Q4 182,263,088 $27,279,872,832 +$121,603,683 $149.68 961
2019 Q3 181,622,542 $24,922,759,526 +$54,809,643 $137.27 876
2019 Q2 180,172,288 $21,191,416,898 +$740,207,726 $117.74 861
2019 Q1 183,114,950 $23,381,967,568 -$20,895,994 $127.70 876
2018 Q4 178,606,178 $18,527,940,380 +$223,246,542 $103.72 842
2018 Q3 180,620,361 $23,739,627,915 +$273,802,958 $131.47 872
2018 Q2 178,638,410 $19,906,163,599 +$142,878,057 $111.44 853
2018 Q1 179,565,930 $19,577,848,177 +$367,932,347 $109.04 864
2017 Q4 174,677,290 $21,075,534,291 -$11,973,631 $120.67 855
2017 Q3 170,286,448 $19,938,272,730 -$143,866,842 $117.09 804
2017 Q2 171,592,440 $22,026,831,804 +$266,231,496 $128.40 804
2017 Q1 169,533,779 $20,685,184,728 +$1,811,668,588 $122.11 803
2016 Q4 171,152,250 $17,664,223,184 -$9,502,863 $103.20 791
2016 Q3 171,842,786 $22,326,621,107 -$448,531,008 $130.02 796
2016 Q2 176,338,931 $21,229,789,171 -$44,129,480 $120.38 754
2016 Q1 175,438,157 $18,704,882,506 -$7,484,517,928 $106.63 728
2015 Q4 248,067,284 $25,448,375,478 +$92,627,392 $102.59 730
2015 Q3 247,365,436 $23,234,253,192 +$322,003,057 $93.93 713
2015 Q2 241,355,999 $26,363,357,386 +$10,614,372,930 $109.23 739
2015 Q1 147,165,821 $17,292,446,213 +$234,418,096 $117.52 753
2014 Q4 144,997,315 $16,447,522,642 +$53,621,288 $113.42 741
2014 Q3 143,440,350 $14,423,569,028 +$150,112,073 $100.55 711
2014 Q2 141,416,624 $14,686,207,192 +$144,347,844 $103.86 696
2014 Q1 139,989,327 $13,241,052,410 -$295,363,530 $94.58 691